Researcher Next
Create account
← Back to directory

Stephen L. Chan

Researcher Next ID · RN-014579

Researcher · Medicine

Chinese University of Hong Kong

, Hong Kong

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
725
Citation count
36,622
H-index
84
i10-index
261

Research interests

Medicine
Hepatocellular Carcinoma Treatment and Prognosis
Cancer Immunotherapy and Biomarkers
Cholangiocarcinoma and Gallbladder Cancer Studies
Pancreatic and Hepatic Oncology Research
Liver Disease Diagnosis and Treatment

Publications

  • Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

    NEJM Evidence · 2022 · 10.1056/evidoa2100070

  • Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

    Journal of Clinical Oncology · 2019 · 10.1200/jco.19.01307

  • Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

    The Lancet Oncology · 2018 · 10.1016/s1470-2045(18)30351-6

  • Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1717002

  • Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

    Journal of Clinical Oncology · 2014 · 10.1200/jco.2014.57.9151

Current projects

    No projects listed.